This report provides up-to-date information regarding the status of NPS benzodiazepine prevalence and positivity in the United States.
Novel psychoactive substances (NPS), including NPS benzodiazepines, continue to pose great challenges for forensic scientists, clinicians, and public health and safety personnel. NPS benzodiazepines have been implicated in an increasing number of adverse health events, marked by emergency room admissions and death investigations, especially when ingested in combination with opioids. Maintaining a current scope of analysis can be challenging, requiring comprehensive analytical methodologies and reference materials for identification(s). (Publisher abstract provided.)
Downloads
Similar Publications
- Development of a spectral X-ray fluorescence database to strengthen the scientific foundations for the forensic analysis and interpretation of modern soda-lime glass
- Assessing the expanded capacity of modern μ-XRF SDD systems for forensic analysis through an interlaboratory study: Part II—Vehicle glass
- Gender differences in gang-involved youth and juvenile justice outcomes: Findings from the Rio Grande Valley